Interview: Markus Arigoni – CEO, Micro-Macinazione, Switzerland

Markus Arigoni, CEO of Ticino-based micronization specialists Micro-Macinazione, describes the scope of the company’s operations, the enlargement of the firm’s R&D capacities, and emerging trends in the micronization niche. Micro-Macinazione SA was founded back in 1970 and has subsequently developed into one of Europe’s most renowned providers of micronization of active ingredients for the pharmaceutical and fine chemical industry. The firm was acquired by Cross Equity Partners in 2012 and has since undergone considerable investment. Could you please start by introducing the scope of your operations today?
"The beauty of jet milling micronization is that it creates the particle collision of crystals without any need for physical contact of metals so, in contrast to mechanical milling, there is minimal resulting debris."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report